Top compounds associated with response to CBL


Feature Type Standardized
Nominal ANOVA
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA quizartinib CTRPv2 pan-cancer AAC -0.013 0.7
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA CH5424802 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA LY317615 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA RAF265 FIMM pan-cancer AAC -0.065 0.7
mRNA DBeQ CTRPv2 pan-cancer AAC 0.012 0.7
mRNA Crizotinib gCSI pan-cancer AAC -0.019 0.7
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.015 0.7
Download CSV